Prognostic factors and early risk-adapted therapy in patients with chronic lymphocytic leukemia in Binet stage A Not provided at time of registration

• Pays Germany
• Organes Aucun
• Spécialités Aucune

Phase III trial of combined immunochemotherapy with Fludarabine, Cyclophosphamide and Rituximab (FC-R) versus chemotherapy with Fludarabine and Cyclophosphamide (FC) alone in patients with previously untreated chronic lymphocytic leukaemia Not provided at time of registration

• Pays Germany
• Organes Aucun
• Spécialités Aucune

Treatment of advanced, relapsed chronic lymphocytic leukemia (CLL) with fludarabine, miroxantrone and cyclophosphamide combination therapy with or without granulocyte colony stimulating factor (G-CSF) Not provided at time of registration

• Pays Germany
• Organes Aucun
• Spécialités Aucune